共 50 条
- [31] LY2969822: Pharmacological Characterization of an Orally Bioavailable Prodrug for a Potent, Selective mGlu2/3 Receptor AgonistCURRENT NEUROPHARMACOLOGY, 2014, 12 : 40 - 40McKinzie, D. L.Johnson, B. J.Knitowski, K.Shaw, D.Rorick-Kehn, L.Katner, J.Perry, K.Swanson, S.Catlow, J.Johnson, M. P.Prieto, L.Beadle, C.Monn, J. A.
- [32] Discovery of TK-642 as a highly potent, selective, orally bioavailable pyrazolopyrazine-based allosteric SHP2 inhibitorACTA PHARMACEUTICA SINICA B, 2024, 14 (08) : 3624 - 3642Tang, KaiWang, ShuFeng, SiqiYang, XinyuGuo, YueyangRen, XiangliBai, LinyueYu, BinLiu, Hong-MinSong, Yihui
- [33] Discovery of potent, highly selective, and orally bioavailable pyridine carboxamide c-jun NH2-terminal kinase inhibitorsJOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (15) : 4455 - 4458Zhao, HongyuSerby, Michael D.Xin, ZhiliSzczepankiewicz, Bruce G.Liu, MeiKosogof, ChristiLiu, BoNelson, Lissa T. J.Johnson, Eric F.Wang, SanyiPederson, TerryGum, Rebecca J.Clampit, Jill E.Haasch, Deanna L.Abad-Zapatero, CeleFry, Elizabeth H.Rondinone, CristinaTrevillyan, James M.Sham, Hing L.Liu, Gang
- [34] TAS-116, a Novel, Orally Bioavailable HSP90a/β Selective Inhibitor Demonstrates Highly Potent Antitumor Activity in Preclinical Models with a Favorable PK ProfileEUROPEAN JOURNAL OF CANCER, 2012, 48 : 89 - 89Ohkubo, S.Muraoka, H.Hashimoto, A.Ito, S.Ito, K.Shibata, Y.Kanoh, A.Kitade, M.Yonekura, K.Utsugi, T.
- [35] A Highly Potent, Orally Bioavailable Pyrazole-Derived Cannabinoid CB2 Receptor- Selective Full Agonist for In Vivo StudiesACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2024, 7 (08) : 2424 - 2438Chicca, AndreaBatora, DanielUllmer, ChristophCaruso, AntonelloGruner, SabineFingerle, Ju''rgenHartung, ThomasDegen, RolandMueller, MatthiasGrether, UwePacher, PalGertsch, Jurg
- [36] Discovery and Characterization of 2-Aminooxazolines as Highly Potent, Selective, and Orally Active TAAR1 AgonistsACS MEDICINAL CHEMISTRY LETTERS, 2016, 7 (02): : 192 - 197Galley, GuidoBeurier, AngelicaDecoret, GuillaumeGoergler, AnnickHutter, RomanMohr, SusannePaehler, AxelSchmid, PhilippTuerck, DietrichUnger, RobertZbinden, Katrin GroebkeHoener, Marius C.Norcross, Roger D.
- [37] Protein kinase B/Akt antagonists as antitumor agents part 4: Syntheses of potent, highly selective and orally bioavailable Akt inhibitors with reduced toxicity.ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U133 - U133Gong, JGandhi, VBLi, TLuo, YShi, YLiu, XKlinghofer, VBouska, JOlson, AShoemaker, AStoll, VSLubbers, NLPolakowski, JBallaron, SCampbell, TJDe Jong, ROltersdorf, TLi, QRosenberg, SHGiranda, VZhu, GD
- [38] Discovery of XL01126: A Potent, Fast, Cooperative, Selective, Orally Bioavailable, and Blood-Brain Barrier Penetrant PROTAC Degrader of Leucine-Rich Repeat Kinase 2JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2022, 144 (37) : 16930 - 16952Liu, XinguiKalogeropulou, Alexia F.Domingos, SofiaMakukhin, NikolaiNirujogi, Raja S.Singh, FrancoisShpiro, NataliaSaalfrank, AntonSammler, EstherGanley, Ian G.Moreira, RuiAlessi, Dario R.Ciulli, Alessio
- [39] Discovery and optimization of a novel series of N-arylamide oxadiazoles as potent, highly selective and orally bioavailable cannabinoid receptor 2 (CB2) agonistsJOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (16) : 5019 - 5034Cheng, YuanAlbrech, Brian K.Brown, JamesBuchanan, John L.Buckner, William H.DiMauro, Erin F.Emkey, ReneeFremeau, Robert T., Jr.Harrnange, Jean-ChristopheHoffman, Beth J.Huang, LiyueHuang, MingLee, Josie HanLin, Fen-FenMartin, Matthew W.Nguyen, Hung Q.Patel, Vinod F.Tomlinson, Susan A.White, Ryan D.Xia, XiaoyangHitchcock, Stephen A.
- [40] A highly selective, orally bioavailable, vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor has potent activity in vitro and in vivoANGIOGENESIS, 2009, 12 (03) : 287 - 296LaMontagne, Kenneth R.Butler, JeanneneBorowski, Virna B.Fuentes-Pesquera, Angel R.Blevitt, Jonathan M.Huang, ShenlinLi, RonghuaConnolly, Peter J.Greenberger, Lee M.